![Daniel F. Voytas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel F. Voytas
Företagsledare/Principal på
University of Minnesota
Profil
Daniel F.
Voytas was the founder of Calyxt, Inc. which was founded in 2010, where he held the title of Chief Science Officer from 2010 to 2021.
Currently, he is the Director-Center for Precision Plant Genomics at the University of Minnesota since 2008.
Dr. Voytas received his doctorate degree from Harvard Medical School in 1990 and his undergraduate degree from Harvard College in 1984.
Aktiva positioner av Daniel F. Voytas
| Företag | Position | Start |
|---|---|---|
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2008-01-01 |
Tidigare kända positioner av Daniel F. Voytas
| Företag | Position | Slut |
|---|---|---|
Calyxt, Inc.
 Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company, engages in development and commercialization of products derived from plant cells | Grundare | 2021-02-01 |
Daniel F. Voytass utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
97
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calyxt, Inc.
Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company, engages in development and commercialization of products derived from plant cells | Commercial Services |
